Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang Klute

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 6, 2011
Discovery of potent, metabolically stable purine CRF-1 antagonists with differentiated binding kinetic profilesDuncan C Miller, Wolfgang Klute, Alan D Brown
Bioorganic & Medicinal Chemistry Letters|September 29, 2009
Optimising metabolic stability in lipophilic chemical space: the identification of a metabolically stable pyrazolopyrimidine CRF-1 receptor antagonistDuncan C Miller, Wolfgang Klute, Andrew Calabrese, et al.
Chemical Communications (Cambridge, England)|February 20, 2004
Self-indicating amine scavenger resinsJin Ku Cho, Peter D White, Wolfgang Klute, et al.
Bioorganic & Medicinal Chemistry Letters|October 2, 2013
Serendipity in drug-discovery: a new series of 2-(benzyloxy)benzamides as TRPM8 antagonistsAlan Brown, David Ellis, David A Favor, et al.
Bioorganic & Medicinal Chemistry|December 13, 2018
The discovery and optimization of benzimidazoles as selective Na<sub>V</sub>1.8 blockers for the treatment of painAlan D Brown, Sharan K Bagal, Paul Blackwell, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2009
The design and discovery of novel amide CCR5 antagonistsDavid C Pryde, Martin Corless, David R Fenwick, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|September 6, 2011
Discovery of potent, metabolically stable purine CRF-1 antagonists with differentiated binding kinetic profilesDuncan C Miller, Wolfgang Klute, Alan D Brown
Bioorganic & Medicinal Chemistry Letters|September 29, 2009
Optimising metabolic stability in lipophilic chemical space: the identification of a metabolically stable pyrazolopyrimidine CRF-1 receptor antagonistDuncan C Miller, Wolfgang Klute, Andrew Calabrese, et al.
Chemical Communications (Cambridge, England)|February 20, 2004
Self-indicating amine scavenger resinsJin Ku Cho, Peter D White, Wolfgang Klute, et al.
Bioorganic & Medicinal Chemistry Letters|October 2, 2013
Serendipity in drug-discovery: a new series of 2-(benzyloxy)benzamides as TRPM8 antagonistsAlan Brown, David Ellis, David A Favor, et al.
Bioorganic & Medicinal Chemistry|December 13, 2018
The discovery and optimization of benzimidazoles as selective Na<sub>V</sub>1.8 blockers for the treatment of painAlan D Brown, Sharan K Bagal, Paul Blackwell, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2009
The design and discovery of novel amide CCR5 antagonistsDavid C Pryde, Martin Corless, David R Fenwick, et al.
Pageof 1